Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by Kobedog1on Apr 30, 2021 1:33pm
238 Views
Post# 33102188

Claritas knows exactly what it is doing, to be sure.

Claritas knows exactly what it is doing, to be sure.We all may not like it. But these guys have a plan. Keeping the share price depressed may or may not be a part of that plan. We will never know. The market makers do what they are told to do. So many folks on this board think simplistically. That sounds arrogant- not meant to be. Look at what half of America is doing to itself. Driven by really simple beliefs grounded in absolutely nothing but blind faith in the b.s. they are fed. These boards have folks that are paid to do the same thing. Muddy the waters.  All we can do is use common sense here. Who holds the patents? That means financing will always be found. So, enjoy the weekend. Ignore the news. 
Help someone when you can. It is a big world full of problems. Many will be overcome. Remember WW2 came to an end eventually. Think on that for the rest of the weekend. 
Kobe from NIagara.  (north of the border, thank goodness).
<< Previous
Bullboard Posts
Next >>